MAJOR — Use With Caution
DANGEROUS — TCA levels increase dramatically + serotonin syndrome risk
Evidence level: STRONG
Zoloft can dangerously increase amitriptyline blood levels and risk serotonin syndrome.
SSRIs inhibit CYP2D6, reducing TCA metabolism and increasing levels 2-4x. Both are serotonergic — combined risk of serotonin syndrome and TCA toxicity.
If combination is necessary, reduce TCA dose by 50-75% and monitor TCA blood levels. Watch for serotonin syndrome.
Take Sertraline at the same time each day — morning is most common to avoid sleep disruption. Amitriptyline follows its prescribed schedule. SSRIs have a long half-life, so consistency matters more than the exact hour.
CYP2D6 poor metabolizers, elderly, cardiac disease
Serotonin syndrome (agitation, tremor, hyperthermia), TCA toxicity (dry mouth, urinary retention, confusion, cardiac arrhythmias, seizures)
TCA blood levels must be monitored. Discuss whether combination is truly necessary.
Discuss this combination with your prescriber. They may adjust timing, dosing, or switch to an alternative with fewer interaction risks. Never stop an antidepressant abruptly — taper under medical guidance.
Zoloft can dangerously increase amitriptyline blood levels and risk serotonin syndrome.
Take Sertraline at the same time each day — morning is most common to avoid sleep disruption. Amitriptyline follows its prescribed schedule. SSRIs have a long half-life, so consistency matters more than the exact hour.
Serotonin syndrome (agitation, tremor, hyperthermia), TCA toxicity (dry mouth, urinary retention, confusion, cardiac arrhythmias, seizures)
Discuss this combination with your prescriber. They may adjust timing, dosing, or switch to an alternative with fewer interaction risks. Never stop an antidepressant abruptly — taper under medical guidance.
TCA blood levels must be monitored. Discuss whether combination is truly necessary.
Or browse the full interaction database (121,000+ pairs).